185 related articles for article (PubMed ID: 14735903)
1. Frequent activation of AKT2 kinase in human pancreatic carcinomas.
Altomare DA; Tanno S; De Rienzo A; Klein-Szanto AJ; Tanno S; Skele KL; Hoffman JP; Testa JR
J Cell Biochem; 2002; 87(4):470-6. PubMed ID: 14735903
[TBL] [Abstract][Full Text] [Related]
2. Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase/Akt pathway in human ovarian cancer.
Yuan ZQ; Sun M; Feldman RI; Wang G; Ma X; Jiang C; Coppola D; Nicosia SV; Cheng JQ
Oncogene; 2000 May; 19(19):2324-30. PubMed ID: 10822383
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylated Akt/PKB controls cell growth and apoptosis in intraductal papillary-mucinous tumor and invasive ductal adenocarcinoma of the pancreas.
Semba S; Moriya T; Kimura W; Yamakawa M
Pancreas; 2003 Apr; 26(3):250-7. PubMed ID: 12657951
[TBL] [Abstract][Full Text] [Related]
4. Frequent genetic and biochemical alterations of the PI 3-K/AKT/PTEN pathway in head and neck squamous cell carcinoma.
Pedrero JM; Carracedo DG; Pinto CM; Zapatero AH; Rodrigo JP; Nieto CS; Gonzalez MV
Int J Cancer; 2005 Mar; 114(2):242-8. PubMed ID: 15543611
[TBL] [Abstract][Full Text] [Related]
5. The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-kappaB and c-Myc in pancreatic cancer cells.
Asano T; Yao Y; Zhu J; Li D; Abbruzzese JL; Reddy SA
Oncogene; 2004 Nov; 23(53):8571-80. PubMed ID: 15467756
[TBL] [Abstract][Full Text] [Related]
6. Genetic alterations and aberrant expression of genes related to the phosphatidyl-inositol-3'-kinase/protein kinase B (Akt) signal transduction pathway in glioblastomas.
Knobbe CB; Reifenberger G
Brain Pathol; 2003 Oct; 13(4):507-18. PubMed ID: 14655756
[TBL] [Abstract][Full Text] [Related]
7. Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells.
St-Germain ME; Gagnon V; Mathieu I; Parent S; Asselin E
Int J Oncol; 2004 May; 24(5):1311-24. PubMed ID: 15067356
[TBL] [Abstract][Full Text] [Related]
8. Correlation between loss of PTEN expression and Akt phosphorylation in endometrial carcinoma.
Kanamori Y; Kigawa J; Itamochi H; Shimada M; Takahashi M; Kamazawa S; Sato S; Akeshima R; Terakawa N
Clin Cancer Res; 2001 Apr; 7(4):892-5. PubMed ID: 11309338
[TBL] [Abstract][Full Text] [Related]
9. Amplification and overexpression of the AKT2 oncogene in a subset of human pancreatic ductal adenocarcinomas.
Ruggeri BA; Huang L; Wood M; Cheng JQ; Testa JR
Mol Carcinog; 1998 Feb; 21(2):81-6. PubMed ID: 9496907
[TBL] [Abstract][Full Text] [Related]
10. AKT activation up-regulates insulin-like growth factor I receptor expression and promotes invasiveness of human pancreatic cancer cells.
Tanno S; Tanno S; Mitsuuchi Y; Altomare DA; Xiao GH; Testa JR
Cancer Res; 2001 Jan; 61(2):589-93. PubMed ID: 11212254
[TBL] [Abstract][Full Text] [Related]
11. Differential mechanisms of constitutive Akt/PKB activation and its influence on gene expression in pancreatic cancer cells.
Matsumoto J; Kaneda M; Tada M; Hamada J; Okushiba S; Kondo S; Katoh H; Moriuchi T
Jpn J Cancer Res; 2002 Dec; 93(12):1317-26. PubMed ID: 12495471
[TBL] [Abstract][Full Text] [Related]
12. Frequent monoallelic deletion of PTEN and its reciprocal associatioin with PIK3CA amplification in gastric carcinoma.
Byun DS; Cho K; Ryu BK; Lee MG; Park JI; Chae KS; Kim HJ; Chi SG
Int J Cancer; 2003 Apr; 104(3):318-27. PubMed ID: 12569555
[TBL] [Abstract][Full Text] [Related]
13. Regulation of phosphoinositide metabolism, Akt phosphorylation, and glucose transport by PTEN (phosphatase and tensin homolog deleted on chromosome 10) in 3T3-L1 adipocytes.
Ono H; Katagiri H; Funaki M; Anai M; Inukai K; Fukushima Y; Sakoda H; Ogihara T; Onishi Y; Fujishiro M; Kikuchi M; Oka Y; Asano T
Mol Endocrinol; 2001 Aug; 15(8):1411-22. PubMed ID: 11463863
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of activated Akt expression in pancreatic ductal adenocarcinoma.
Yamamoto S; Tomita Y; Hoshida Y; Morooka T; Nagano H; Dono K; Umeshita K; Sakon M; Ishikawa O; Ohigashi H; Nakamori S; Monden M; Aozasa K
Clin Cancer Res; 2004 Apr; 10(8):2846-50. PubMed ID: 15102693
[TBL] [Abstract][Full Text] [Related]
15. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas.
Kurose K; Zhou XP; Araki T; Cannistra SA; Maher ER; Eng C
Am J Pathol; 2001 Jun; 158(6):2097-106. PubMed ID: 11395387
[TBL] [Abstract][Full Text] [Related]
16. Positive feedback regulation between AKT activation and fatty acid synthase expression in ovarian carcinoma cells.
Wang HQ; Altomare DA; Skele KL; Poulikakos PI; Kuhajda FP; Di Cristofano A; Testa JR
Oncogene; 2005 May; 24(22):3574-82. PubMed ID: 15806173
[TBL] [Abstract][Full Text] [Related]
17. mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma.
Hu X; Pandolfi PP; Li Y; Koutcher JA; Rosenblum M; Holland EC
Neoplasia; 2005 Apr; 7(4):356-68. PubMed ID: 15967113
[TBL] [Abstract][Full Text] [Related]
18. Phosphatidylinositol-3-OH Kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor alpha (ERalpha) via interaction between ERalpha and PI3K.
Sun M; Paciga JE; Feldman RI; Yuan Z; Coppola D; Lu YY; Shelley SA; Nicosia SV; Cheng JQ
Cancer Res; 2001 Aug; 61(16):5985-91. PubMed ID: 11507039
[TBL] [Abstract][Full Text] [Related]
19. Activation of PI3K/Akt pathway by PTEN reduction and PIK3CA mRNA amplification contributes to cisplatin resistance in an ovarian cancer cell line.
Lee S; Choi EJ; Jin C; Kim DH
Gynecol Oncol; 2005 Apr; 97(1):26-34. PubMed ID: 15790433
[TBL] [Abstract][Full Text] [Related]
20. Activation of PPARgamma increases PTEN expression in pancreatic cancer cells.
Farrow B; Evers BM
Biochem Biophys Res Commun; 2003 Jan; 301(1):50-3. PubMed ID: 12535639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
